4640 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. Abou-Alfa
    Abou-Alfa
  4. Kelsen
    Kelsen
  5. Ilson
    Ilson
  6. Kemeny
    Kemeny
  7. Janjigian
    Janjigian
  8. Reidy
    Reidy
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)
  7. Epidemiology and Biostatistics (828)
  8. GSK Faculty (793)
  9. Department of Pathology and Laboratory Medicine (723)
  10. Biostatistics Service (661)
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective molecular evaluation of small cell lung cancer (SCLC) utilizing the comprehensive mutation analysis program (MAP) at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Krug, L. M.; Pietanza, M. C.; Varghese, A. M.; Won, H.; Wang, L.; Rekhtman, N.; Travis, W. D.; Litvak, A.; Paik, P. K.; Riely, G. J.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Survival, response duration, and activity by BRAF mutation (MT) status in a phase 1 trial of nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Kluger, H.; Sznol, M.; Callahan, M.; Postow, M.; Gordon, R.; Segal, N. H.; Rizvi, N.; Lesokhin, A.; Atkins, M. B.; Kirkwood, J.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Biomarker analysis in Phase 1b study of anti-cancer stem cell antibody Tarextumab (TAR) in combination with nab-paclitaxel and gemcitabine (Nab-P+Gem) demonstrates pharmacodynamic (PD) modulation of the Notch pathway in patients (pts) with untreated metastatic pancreatic cancer (mPC)
    Meeting Abstract

    Kapoun, A.; O'reilly, E.; Cohn, A.; Bendell, J. C.; Smith, L.; Strickler, J. H.; Gluck, W.; Liu, Y. W.; Wallace, B.; Tam, R.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer
    Journal Article

    Cercek, A.; Shia, J.; Gollub, M.; Chou, J. F.; Capanu, M.; Raasch, P.; Reidy-Lagunes, D.; Proia, D. A.; Vakiani, E.; Solit, D. B.; more...
    Clinical Colorectal Cancer (2014)

    Fulltext@MSK | Save
  • APACT: A phase III trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone as adjuvant therapy for patients with resected pancreatic cancer (PC)
    Meeting Abstract

    Tempero, M.; Cardin, D.; Biankin, A.; Goldstein, D.; Moore, M.; O'reilly, E.; Philip, P.; Riess, H.; Macarulla, T.; Yung, L.; more...
    American Journal of Gastroenterology (2014)

    Fulltext@MSK | Save
  • Continued afatinib (A) with the addition of cetuximab (C) after progression on afatinib in patients with acquired resistance (AR) to gefitinib (G) or erlotinib (E)
    Meeting Abstract

    Horn, L.; Gettinger, S.; Camidge, R.; Smit, E.; Janjigian, Y.; Pao, W.; Schnell, D.; Wang, B.; Chand, V.; Groen, H.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Advancing clinical oncology through genome biology and technology
    Journal Article

    Varghese, A. M.; Berger, M. F.
    Genome Biology (2014)

    Fulltext@MSK | Save
  • Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions
    Journal Article

    Brannon, A. R.; Vakiani, E.; Sylvester, B. E.; Scott, S. N.; McDermott, G.; Shah, R. H.; Kania, K.; Viale, A.; Oschwald, D. M.; Vacic, V.; more...
    Genome Biology (2014)

    Fulltext@MSK | Save
  • Current state of the art and science of patient-clinician communication in progressive disease: Patients' need to know and need to feel known
    Journal Article

    van Vliet, L. M.; Epstein, A. S.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases
    Journal Article

    Kemeny, N. E.; Chou, J. F.; Capanu, M.; Gewirtz, A. N.; Cercek, A.; Kingham, T. P.; Jarnagin, W. R.; Fong, Y.; DeMatteo, R. P.; Allen, P. J.; more...
    Cancer (2014)

    Fulltext@MSK | Save